Latest stories on QGEN
Qiagen downgraded to Equal Weight from Overweight at Barclays
The Fly34 · bearishanalyst
Qiagen price target raised to $52 from $45 at Citi
The Fly63 · neutralanalyst
Qiagen: Unanimous Acceptance Takeover Nears Close (Rating Downgrade)
Seeking Alpha74 · bullishm&a
QIAGEN Agrees to €46.50-Per-Share Takeover by Crown NL Bidco
TipRanks74 · bullishm&a
Qiagen downgraded to Hold from Buy at DZ Bank
The Fly34 · bearishanalyst
Halper Sadeh LLC is Investigating Whether QGEN, VCTR, RLYB are Obtaining Fair Deals for their Shareholders
GlobeNewswire34 · bearishgeneral
Qiagen downgraded to Neutral from Outperform at Baird
The Fly34 · bearishanalyst
Qiagen moved to No Rating at BofA
The Fly42 · neutralanalyst
Qiagen agrees to €46.50/share all-cash takeover offer from EQT
Seeking Alpha74 · bullishm&a
Qiagen downgraded to Neutral from Overweight at JPMorgan
The Fly34 · bearishanalyst
JPMorgan downgrades Qiagen stock rating on EQT buyout deal
Investing.com Analyst Ratings34 · bearishanalyst
Qiagen reports preliminary Q3 results
Seeking Alpha50 · neutralearnings
Buyout firm EQT acquires German diagnostics group in €10.8bn deal
Financial Times58 · neutralm&a
EQT-Led Coalition Reaches Deal to Take Qiagen Private at $12.1B Enterprise Value
MarketWatch64 · neutralm&a
Qiagen, EQT Private Equity announce $12.1B all-cash takeover offer
The Fly74 · bullishm&a
Qiagen suspends 2026 outlook
The Fly34 · bearishearnings
Qiagen sees Q3 adjusted EPS 65c, consensus 62c
The Fly63 · neutralearnings
QIAGEN reports preliminary Q3 2026 results
StockTitan52 · neutralearnings
Qiagen gains on report EQT nearing €9.6B deal
Seeking Alpha64 · neutralm&a
EQT near acquisition of Qiagen for EUR 46.50 per share, Bloomberg says
The Fly74 · bullishm&a
Qiagen up 1% to $49.36 after Bloomberg report of possible EQT deal
The Fly63 · neutralm&a
EQT near deal to acquire Qiagen for $10.8B, Bloomberg reports
The Fly74 · bullishm&a